CYC cyclopharm limited

Ann: Nuclear imaging trial aiming to clear up airway diagnosis, page-4

  1. 900 Posts.
    lightbulb Created with Sketch. 129
    CYC is not a trader's stock.
    Volume so low generally that it could go either way in the short term.
    Value at this level still.
    It will move on new supplier deals being announced, and then on results in the US and the AU trials, but still 12 months or more away. Plus Ultralute (still under wraps)
    Barring the above, expect next report to be incremental gains.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
91.0¢
Change
-0.020(2.15%)
Mkt cap ! $100.0M
Open High Low Value Volume
93.0¢ 93.0¢ 89.5¢ $49.79K 54.78K

Buyers (Bids)

No. Vol. Price($)
2 3022 90.0¢
 

Sellers (Offers)

Price($) Vol. No.
91.5¢ 525 1
View Market Depth
Last trade - 14.37pm 30/06/2025 (20 minute delay) ?
CYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.